MicroRNA signature predicts survival and relapse in lung cancer - PubMed (original) (raw)
doi: 10.1016/j.ccr.2007.12.008.
Hsuan-Yu Chen, Gee-Chen Chang, Chih-Yi Chen, Huei-Wen Chen, Sher Singh, Chiou-Ling Cheng, Chong-Jen Yu, Yung-Chie Lee, Han-Shiang Chen, Te-Jen Su, Ching-Cheng Chiang, Han-Ni Li, Qi-Sheng Hong, Hsin-Yuan Su, Chun-Chieh Chen, Wan-Jiun Chen, Chun-Chi Liu, Wing-Kai Chan, Wei J Chen, Ker-Chau Li, Jeremy J W Chen, Pan-Chyr Yang
Affiliations
- PMID: 18167339
- DOI: 10.1016/j.ccr.2007.12.008
Free article
MicroRNA signature predicts survival and relapse in lung cancer
Sung-Liang Yu et al. Cancer Cell. 2008 Jan.
Free article
Abstract
We investigated whether microRNA expression profiles can predict clinical outcome of NSCLC patients. Using real-time RT-PCR, we obtained microRNA expressions in 112 NSCLC patients, which were divided into the training and testing sets. Using Cox regression and risk-score analysis, we identified a five-microRNA signature for the prediction of treatment outcome of NSCLC in the training set. This microRNA signature was validated by the testing set and an independent cohort. Patients with high-risk scores in their microRNA signatures had poor overall and disease-free survivals compared to the low-risk-score patients. This microRNA signature is an independent predictor of the cancer relapse and survival of NSCLC patients.
Similar articles
- A 25-signal proteomic signature and outcome for patients with resected non-small-cell lung cancer.
Yanagisawa K, Tomida S, Shimada Y, Yatabe Y, Mitsudomi T, Takahashi T. Yanagisawa K, et al. J Natl Cancer Inst. 2007 Jun 6;99(11):858-67. doi: 10.1093/jnci/djk197. J Natl Cancer Inst. 2007. PMID: 17551146 Clinical Trial. - Evaluation of microRNA expression profiles that may predict recurrence of localized stage I non-small cell lung cancer after surgical resection.
Patnaik SK, Kannisto E, Knudsen S, Yendamuri S. Patnaik SK, et al. Cancer Res. 2010 Jan 1;70(1):36-45. doi: 10.1158/0008-5472.CAN-09-3153. Epub 2009 Dec 22. Cancer Res. 2010. PMID: 20028859 - A five-gene signature and clinical outcome in non-small-cell lung cancer.
Chen HY, Yu SL, Chen CH, Chang GC, Chen CY, Yuan A, Cheng CL, Wang CH, Terng HJ, Kao SF, Chan WK, Li HN, Liu CC, Singh S, Chen WJ, Chen JJ, Yang PC. Chen HY, et al. N Engl J Med. 2007 Jan 4;356(1):11-20. doi: 10.1056/NEJMoa060096. N Engl J Med. 2007. PMID: 17202451 - Genomic medicine in non-small cell lung cancer: paving the path to personalized care.
Sriram KB, Larsen JE, Yang IA, Bowman RV, Fong KM. Sriram KB, et al. Respirology. 2011 Feb;16(2):257-63. doi: 10.1111/j.1440-1843.2010.01892.x. Respirology. 2011. PMID: 21044232 Review. - Role of microRNAs in lung cancer: microRNA signatures in cancer prognosis.
Boeri M, Pastorino U, Sozzi G. Boeri M, et al. Cancer J. 2012 May-Jun;18(3):268-74. doi: 10.1097/PPO.0b013e318258b743. Cancer J. 2012. PMID: 22647364 Review.
Cited by
- Profiling of Small Nucleolar RNAs by Next Generation Sequencing: Potential New Players for Breast Cancer Prognosis.
Krishnan P, Ghosh S, Wang B, Heyns M, Graham K, Mackey JR, Kovalchuk O, Damaraju S. Krishnan P, et al. PLoS One. 2016 Sep 15;11(9):e0162622. doi: 10.1371/journal.pone.0162622. eCollection 2016. PLoS One. 2016. PMID: 27631501 Free PMC article. - MicroRNA as Biomarkers and Diagnostics.
Wang J, Chen J, Sen S. Wang J, et al. J Cell Physiol. 2016 Jan;231(1):25-30. doi: 10.1002/jcp.25056. J Cell Physiol. 2016. PMID: 26031493 Free PMC article. Review. - Association of tumour microRNA profiling with outcomes in patients with advanced urothelial carcinoma receiving first-line platinum-based chemotherapy.
Bellmunt J, Zhou CW, Mullane SA, Werner L, Taplin ME, Fay AP, Choueiri TK, Orsola A, Takeda DY, Hahn WC, Kim J, Sonpavde G, Bowden M. Bellmunt J, et al. Br J Cancer. 2016 Jun 28;115(1):12-9. doi: 10.1038/bjc.2016.146. Epub 2016 Jun 23. Br J Cancer. 2016. PMID: 27351382 Free PMC article. - Clinical outcome prediction by microRNAs in human cancer: a systematic review.
Nair VS, Maeda LS, Ioannidis JP. Nair VS, et al. J Natl Cancer Inst. 2012 Apr 4;104(7):528-40. doi: 10.1093/jnci/djs027. Epub 2012 Mar 6. J Natl Cancer Inst. 2012. PMID: 22395642 Free PMC article. Review. - MetastamiRs: non-coding MicroRNAs driving cancer invasion and metastasis.
Lopez-Camarillo C, Marchat LA, Arechaga-Ocampo E, Perez-Plasencia C, Moral-Hernandez OD, Castaneda-Ortiz EJ, Rodriguez-Cuevas S. Lopez-Camarillo C, et al. Int J Mol Sci. 2012;13(2):1347-1379. doi: 10.3390/ijms13021347. Epub 2012 Jan 27. Int J Mol Sci. 2012. PMID: 22408395 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical